Total Credits: 1.0 including 1.0 AOA Category 1-A Credit(s), 1.0 AMA PRA Category 1 Credit(s)™
Type 2 Diabetes – Taming the Beast
Karen Acevedo-Mogharbel, DO
Dr. Acevedo-Mogharbel discloses she is on the Speakers’ Bureau for Novo Nordisk
Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
The AOMA designates this activity for a maximum of 1.0 hour of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AOMA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
GRIEVANCE POLICY
All grievances should be forwarded to the AOMA Executive Director, Matt Helms, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 3901 W. Peoria Ave., Suite C102-158, Phoenix, AZ 85029 or by email info@azosteo.org.
|
Type 2 Diabetes - Taming the Beast
(760.5 KB)
Karen Acevedo-Mogharbel, DO |
Available after Purchase | ||
Dr. Acevedo-Mogharbel graduated from Nova-Southeastern College of Osteopathic Medicine. Her Internship and residency were completed at St. Vincent's Mercy Medical Center 2000-2003.
Dr. Acevedo-Mogharbel is board certified in family medicine. She has been a preceptor for Midwestern College of Osteopathic Medicine since 2017. She has her own practice that she started in 2004. She is the current president of the Arizona state society of the American College of Osteopathic Physicians.
She is Married, Mother of 4 accomplished children and Amma to 3 grandbabies. She enjoys outdoor bike riding, spin class, crocheting, adventure, mythical and sci-fi movies.
Dr. Acevedo-Mogharbel has no disclosures.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|